Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
8
80%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(7)
Other(2)

Detailed Status

Completed7
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (11.1%)
N/A8 (88.9%)

Trials by Status

completed770%
recruiting110%
unknown220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10